|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
Back to Medical News Today Archives
Medical News Today: 02-22-2005
A form of beta blocker, a drug commonly used to lower blood pressure and ward off repeat heart attacks, may provide the answer to preventing osteoporosis, said a Baylor College of Medicine researcher... click link for more info.
Tissue engineers can choose from a wide range of living cells, biomaterials and proteins to repair a bone defect... click link for more info.
Air pollution, and especially particulate matter, thickens the blood and boosts inflammation, finds experimental research in Occupational and Environmental Medicine... click link for more info.
Regular users of cannabis could be putting themselves at risk of stroke, while they are still young, indicates a case report, published in the Journal of Neurology Neurosurgery and Psychiatry... click link for more info.
Slow growth in the year after birth seems to signal poor economic prospects as an adult, suggests a study of 50 year old men in Archives of Disease in Childhood... click link for more info.
Severely hyperactive children are three times more likely to be removed from their families, because their parents can no longer cope, than children with other mental health or behavioural problems, reveals research in Archives of Disease in Childhood... click link for more info.
In the first comprehensive examination of strenuous physical activity and the risk of developing Parkinson's disease, researchers from the Harvard School of Public Health (HSPH) have found that men who exercised regularly and vigorously early in their adult life had a lower risk for developing Parkinson's disease compared to men who did not... click link for more info.
Thanks to a handful of very special mice, scientists have discovered a new tumor suppressor gene and a unique chemical signature implicated in the development of human leukemia, findings that open up a "treasure box" of opportunity and possibility, study authors say... click link for more info.
Second Annual Heart Health Survey Indicates Northern California Women Are More Aware, But Still Don't Personalize Their Risk for a Heart Attack - In the second year of a Northern California-based survey conducted by Sutter Health on women and heart disease, results show that more women are aware of heart attack warning signs and the need to take action quickly... click link for more info.
The National Society of Genetic Counselors (NSGC) fully supports the Senate's passage of the Genetic Non- Discrimination Bill (S... click link for more info.
An innovative new procedure that uses cooling therapy continues to show success in remedying difficult-to-treat blood vessel blockages, according to independent data presented by a Texas Heart Institute physician at the International Congress on Endovascular Intervention XVIII... click link for more info.
Three-Year Study With RAPTIVA(R) Showed Long-Term and Sustained Clearing in Moderate-To-Severe Plaque Psoriasis Patients - New Results Presented Today at American Academy of Dermatology Meeting - Genentech, Inc today presented final results from a long-term study that showed sustained improvement in psoriasis symptoms throughout three years of continuous treatment with RAPTIVA(R) (efalizumab)... click link for more info.
USA - The third wave of a study conducted by Market Strategies' (MSI) Global Life Sciences Division indicates oncologists have implemented or plan to implement some significant changes within their practices to offset the expected decline in reimbursement due to Medicare Reform... click link for more info.
Rhytec, Inc Introduces Portrait(R) Skin Regeneration at American Academy of Dermatology Meeting February 17-21, 2005 in New Orleans - Portrait(R) Skin Regeneration is the first and only clinically proven technology delivering true skin regeneration, resulting in reduced wrinkles and improved skin tone and texture with minimal downtime... click link for more info.
USA - Millions More Beneficiaries to Have Better Choices Through Medicare Advantage, Karen Ignagni - Karen Ignagni, President and CEO of America's Health Insurance Plans (AHIP), made the following statement regarding today's announcement by the Centers for Medicare & Medicaid Services (CMS) of the unprecedented number of new contract applications for participation in the Medicare Advantage program: "Today's preliminary rate announcement by CMS comes amid mounting evidence that as a result of the Medicare Modernization Act, millions more beneficiaries will have access to better choices and comprehensive health care coverage... click link for more info.
Strategic Analysis of the Opportunities for the Pharmaceutical and Biotechnology Industry in the 'New' EU Countries - In contrast to subdued growth in the pharmaceutical markets of the former 15-state European Union (EU), pharmaceutical markets in the 'new' EU accession markets are expanding vibrantly... click link for more info.
Dendreon Corporation announced that results from its NCI-sponsored Phase 2 study of Provenge(R), in combination with Avastin(TM) (bevacizumab), increased PSA doubling time (PSADT) in patients with prostate cancer that had relapsed after prior surgical and radiation therapy... click link for more info.
Millennium Pharmaceuticals, Inc... click link for more info.
Researchers at Dana-Farber Cancer Institute in Boston have devised a mathematical tool that predicts how the frequency of mammograms affects the number of lives saved by detecting breast cancers at an earlier stage... click link for more info.
As a result, governments and health officials need to begin to think about how to respond to an anticipated increase in the number and scope of climate-related health crises, ranging from killer heat waves and famine, to floods and waves of infectious diseases... click link for more info.
The FSA has today updated the list of food products affected by Sudan I contamination with a further 38 new items... click link for more info.
A transplant is the only option for someone with end-stage liver disease, but patients face difficult questions when choosing the best time to receive a transplant... click link for more info.
If you crammed for tests by pulling 'all nighters' in school, ever wonder why your memory is now a bit foggy on what you learned? A University of Houston professor may have the answer with his research on the role of circadian rhythms in long-term learning and memory... click link for more info.
Two McMaster University studies, to be published in the Journal of Virology, show that sex hormones have a profound effect on susceptibility of female mice to the herpes simplex virus, type 2 (HSV-2 ), one of the most common sexually transmitted diseases... click link for more info.
Objective Tool May Help Patients Avoid Chemotherapy- An experimental prognostic assay that, at the time of diagnosis, identifies which breast cancer patients are at greatest risk for metastatic disease did so with more than 90 percent sensitivity, according to a study published in The Lancet (February 19, 2005; vol... click link for more info.
GSK Consumer Healthcare Stop-Smoking Products Significantly Increase Quit Rate for Smokers Who Need to Quit the Most- An article in the current issue of the Journal of Substance Abuse Treatment (Volume 28, Issue 1, 2005) provides new hope for smokers who are highly dependent upon tobacco and who smoke more than two packs per day... click link for more info.
Committee makes recommendation after reviewing data package supporting the product`s safety and efficacy profile - Eli Lilly and Company and Boehringer Ingelheim today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of duloxetine for the treatment of diabetic peripheral neuropathic pain in adults... click link for more info.
Data Also Show Many ENBREL Patients Experienced Improvements in Symptoms and the Impact of the Disease on Their Daily Life - At three months, nearly 30 percent of 311 patients with moderate-to-severe psoriasis who were taking Enbrel(R) (etanercept) reported that they were "not at all" bothered by their psoriasis, as indicated by their achieving a "zero" score on the Dermatology Life Quality Index (DLQI) measure... click link for more info.
Psoriasis patients receiving HUMIRA® (adalimumab) achieved significant improvement in disease activity and quality of life through 60 weeks of treatment, according to new Phase II study results released today... click link for more info.
People who have been diagnosed and treated for either chlamydia or gonorrhea and are given medication to provide to their sexual partners are less likely to become reinfected than people who are told to contact their partners to encourage them to seek treatment, according to a study published in the Feb... click link for more info.
The Indiana House Committee on Public Policy and Veterans Affairs on Wednesday approved a bill... click link for more info.
The Arizona House Health Committee on Wednesday approved 6-3 a proposed constitutional amendment... click link for more info.
... click link for more info.
The legalization of prescription drug reimportation from Canada could affect the ability of the United States to negotiate trade agreements and could reduce the number of new medications developed, Grant Aldonas, undersecretary for international trade administration at the... click link for more info.
The Senate on Thursday voted 98-0 in favor of a bill... click link for more info.
At a hearing on Bush's proposed fiscal year 2006 federal budget on Thursday,... click link for more info.
Amit Sachdev, deputy commissioner for policy at... click link for more info.
Researchers have developed ever more sensitive ways of peering into the brain to seek out explanations for brain disease... click link for more info.
Researchers have discovered that marine seaweeds have a remarkable and previously unknown capacity to detoxify serious organic pollutants such as TNT or polycyclic aromatic hydrocarbons, and they may therefore be able to play an important role in protecting the ecological health of marine life... click link for more info.
A laboratory study led by researchers at Dana-Farber Cancer Institute has shown that a potent and highly selective therapy for chronic myelogenous leukemia (CML) may ultimately be more effective than Gleevec®, the current standard of care... click link for more info.
|
|